Search results for "autoantibodie"

showing 10 items of 294 documents

Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.

2006

PURPOSE Glaucoma is characterized by a progressive loss of retinal ganglion cells that results in a characteristic optic neuropathy associated with visual field loss. In previous studies, changes in the antibody profiles have been shown in the sera of patients with glaucoma, and these findings suggest a role for autoimmune involvement in the pathogenesis of glaucoma in some patients. The purpose of this study was to compare the antibody profiles against optic nerve antigens in patients with glaucoma in two different study populations from Germany and the United States. METHODS One hundred twenty patients were included in the study, 60 from Germany and 60 from the United States: a control gr…

Malegenetic structuresOpen angle glaucomaBlotting WesternMolecular Sequence DataGlaucomaEnzyme-Linked Immunosorbent AssayNerve Tissue ProteinsRetinal ganglionAutoantigensGas Chromatography-Mass SpectrometryOptic neuropathyAntigenGermanymedicineHumansAmino Acid SequenceEye ProteinsIntraocular PressureAgedAutoantibodiesbusiness.industryMicrofilament ProteinsAutoantibodyMiddle Agedmedicine.diseaseeye diseasesUnited StatesImmunologyOptic nervePopulation studyFemalesense organsbusinessCarrier ProteinsGlaucoma Open-AngleInvestigative ophthalmologyvisual science
researchProduct

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

2014

Importance The disease process leading to clinical type 1 diabetes often starts during the first years of life. Early exposure to complex dietary proteins may increase the risk of β-cell autoimmunity in children at genetic risk for type 1 diabetes. Extensively hydrolyzed formulas do not contain intact proteins. Objective To test the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of diabetes-associated autoantibodies in young children. Design, Setting, and Participants A double-blind randomized clinical trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited from May 2002 to Ja…

Maleinsulin-Secreting CellsautoantibodiesAutoimmunity2700 General MedicineGastroenterologylaw.invention0302 clinical medicineRandomized controlled trialnewbornlawCaseindouble-blind methodCumulative incidence030212 general & internal medicinehumans: Multidisciplinary general & others [D99] [Human health sciences]childHazard ratioGeneral Medicinefollow-up studiesInfant Formulaanimalscaseinstype 1femaleMilkbreast feedinghydrolysisdiabetes mellitusRiskmedicine.medical_specialty: Multidisciplinaire généralités & autres [D99] [Sciences de la santé humaine]β-cell autoimmunity610 Medicine & health030209 endocrinology & metabolismWeaningArticlehydrolyzed infant formula03 medical and health sciencesInternal medicineDiabetes mellitusHydrolyzed infant formula and early β-cell autoimmunitymedicineanimals; autoantibodies; breast feeding; caseins; child; diabetes mellitus; type 1; dietary proteins; double-blind method; female; follow-up studies; humans; hydrolysis; incidence; infant; newborn; insulin-Secreting Cells; Male; Milk; Risk; Weaning; Autoimmunity; Infant FormulaType 1 diabetesbusiness.industrydietary proteinsta1183Infant Newbornmedicine.diseaseta3123infantDiabetes Mellitus Type 1EndocrinologyInfant formula10036 Medical ClinicincidencebusinessBreast feeding
researchProduct

Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

2011

Background Several epidemiological studies showed a close association between metabolic control and microvascular complications in type 1 Diabetes Mellitus (T1DM). The aim of our longitudinal observational study was to evaluate the predictive role of the main clinical and biochemical parameters in determining microvascular complications. Methods 376 T1DM patients, hospitalized in our division from 1991 to 2005 (mean follow-up = 10.93 ± 4.26 years) were studied. Stepwise Cox regression analysis was used to identify the influence of residual ß-cell function, ß-cell autoimmunity, HbA1c levels and other clinical and laboratory parameters in the development of microalbuminuria and retinopathy. R…

Malemedicine.medical_specialtyAdolescentendocrine system diseasesSettore MED/13 - EndocrinologiaNephropathyYoung AdultPredictive Value of TestsInsulin-Secreting CellsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansDiabetic NephropathiesLongitudinal StudiesAge of OnsetChildAutoantibodiesProportional Hazards ModelsGlycated HemoglobinInpatientsType 1 diabetesDiabetic Retinopathybusiness.industryMicrocirculationMicroangiopathyType 1 diabetes microvascular Complicationsnutritional and metabolic diseasesmedicine.diseaseSurgeryDiabetes Mellitus Type 1Metabolic control analysisPredictive value of testsFemaleMicroalbuminuriaAge of onsetbusinessDiabetic AngiopathiesFollow-Up StudiesEuropean Journal of Internal Medicine
researchProduct

ATP4A autoimmunity in pediatric patients with type 1 diabetes and its relationship to blood count, iron metabolism, and vitamin B12

2017

Objective We aimed to assess the prevalence of autoantibodies against the 4A subunit of the gastric proton pump (ATP4A) in pediatric type 1 diabetes (T1D) patients and explore the relationship between ATP4A positivity and blood cell count, iron turnover, and vitamin B12 concentration. Subjects The study included 94 (59% female) T1D children (aged 12.5 ± 4.1 years, T1D duration 4.2 ± 3.6 years, HbA1c 7.3 ± 1.5% (57 ± 12.6 mmol/mol) with no other autoimmune diseases. Methods ATP4A antibodies were measured in T1D patients using a radioimmunoprecipitation assay. Blood cell count, iron concentration, total iron binding capacity, ferritin, transferrin, hepcidin, and vitamin B12 concentration were…

Malemedicine.medical_specialtyAdolescenttype 1 diabetesEndocrinology Diabetes and MetabolismIron030209 endocrinology & metabolismCohort Studies03 medical and health sciencesH(+)-K(+)-Exchanging ATPaseYoung Adult0302 clinical medicineTotal iron-binding capacityHepcidinInternal medicineInternal MedicinemedicineHumansVitamin B12ChildAutoantibodieschemistry.chemical_classificationType 1 diabetesgastric autoimmunitymedicine.diagnostic_testbiologybusiness.industryferritinAutoantibodynutritional and metabolic diseasesIron deficiencyvitamin B12medicine.diseaseBlood Cell CountFerritinVitamin B 12EndocrinologyDiabetes Mellitus Type 1chemistryTransferrin030220 oncology & carcinogenesisChild PreschoolATP4A antibodiesPediatrics Perinatology and Child Healthbiology.proteinFemalebusinessPediatric Diabetes
researchProduct

Low Prevalence of Celiac Disease among Patients with Functional Gastrointestinal Disorders in Latvia.

2020

Background and Aims: Studies suggest that the prevalence of celiac disease (CD) is increased in individuals with functional gastrointestinal disorders (FGIDs), in particular, irritable bowel syndrome (IBS); however, the evidence is conflicting. We aimed to analyze the prevalence of CD in patients with FGIDs in Latvia.
 Methods: This retrospective study included patients with FGIDs, referred for a gastroenterologist consultation in a secondary gastroenterology practice unit. Patients were divided into three groups – patients only with IBS (IBS group), patients only with functional dyspepsia (FD) (FD group), patients with mixed symptoms IBS and FD (Mixed group). Patient levels of tissue …

Malemedicine.medical_specialtyGastrointestinal DiseasesDiseaseGastroenterologySerologyIrritable Bowel SyndromeGTP-Binding ProteinsInternal medicineBiopsymedicinePrevalenceHumansMixed groupIn patientProtein Glutamine gamma Glutamyltransferase 2Serologic TestsDuodenoscopyIrritable bowel syndromeAutoantibodiesRetrospective StudiesRoutine screeningTransglutaminasesmedicine.diagnostic_testbusiness.industryGastroenterologyRetrospective cohort studyMiddle Agedmedicine.diseaseLatviaImmunoglobulin ACeliac DiseaseFemaleSymptom AssessmentbusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Leucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-Interferons

2003

Background: Alpha-interferon (α-IFN) is the treatment of choice for chronic hepatitis C but most patients experience adverse effects which sometimes lead to the suspension of therapy. Recently, higher doses of α-IFN or prolonged therapy have increased the number of cases of intolerance. Study Design: In this open study we evaluated the efficacy and safety of leucocyte interferon-alpha (IFNα) [6MU three times a week] in 43 patients with chronic hepatitis C who had been intolerant to previous treatment courses with recombinant or lymphoblastoid IFNα. All patients were treated for 6 months and followed-up for an additional 6 months. End of treatment responders were patients in whom hepatitis C…

Malemedicine.medical_specialtyHepatitis C virusAlpha interferonmedicine.disease_causeAntiviral AgentsInjections IntramuscularGastroenterologyPharmacotherapyInternal medicineLeukocytesHumansImmunology and AllergyMedicinePharmacology (medical)Adverse effectPharmacologybiologybusiness.industryInterferon-alphaGeneral MedicineHepatitis C ChronicMiddle AgedMolecular medicineAnti-thyroid autoantibodiesDiscontinuationPharmacology Toxicology and Pharmaceutics (all)Immunologybiology.proteinFemaleAntibodybusinessBiotechnologyBioDrugs
researchProduct

The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions.

2017

Abstract Background: Serum autoantibodies against tumor-associated antigens (TAAs) are detectable in early-stage gastric cancer patients; however, the time point during cancerogenesis when they appear in circulation is still obscure. Methods: In this study, we developed a recombinant antigen microarray and analyzed the prevalence of autoantibodies against 102 TAAs in 829 gastric cancer patients and 929 healthy controls from Caucasian and Asian populations, as well as 100 patients with chronic atrophic gastritis and 775 individuals staged according to different grades of intestinal metaplasia. Results: Six antigens, including CTAG1B/CTAG2, DDX53, IGF2BP2, TP53, and MAGEA3, were predominantly…

Malemedicine.medical_specialtyMAGEA3EpidemiologyAtrophic gastritisGastroenterology03 medical and health sciences0302 clinical medicineAntigenStomach NeoplasmsInternal medicinemedicinePrevalenceHumansAutoantibodiesbiologybusiness.industryStomachAutoantibodyIntestinal metaplasiaCancerHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationdigestive system diseasesmedicine.anatomical_structureOncology030220 oncology & carcinogenesisImmunology030211 gastroenterology & hepatologyFemaleNeoplasm GradingbusinessPrecancerous ConditionsCancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
researchProduct

Response to Villanacci et al.

2013

REFERENCES 1 . Carroccio A , Mansueto P , Iacono G et al. Nonceliac wheat sensitivity diagnosed by doubleblind placebo-controlled challenge: exploring a new clinical entity . Am J Gastroenterol 2013 (this issue) . 2 . Ludvigsson JF , Le$ er DA , Bai JC et al. " e Oslo de! nitions for coeliac disease and related terms . Gut 2013 ; 62 : 43 – 52 . 3 . Sapone A , Bai JC , Ciacci C et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classi! cation . BMC Med 2012 ; 10 – 13 . 4 . Ferch CC , Chey WD . Irritable bowel syndrome and gluten sensitivity without celiac disease: separating the wheat from the cha% . Gastroenterology 2012 ; 142 : 664 – 6 . 5 . Biesiekierski JR , N…

Malemedicine.medical_specialtyPathologySettore MED/09 - Medicina InternaHepatologybusiness.industryNon-celiac gluten sensitivityGastroenterologyGluten sensitivitymedicine.diseaseGastroenterologyCoeliac diseaseGliadinInternal medicineMedicineHumansFemalebusinessNon-celiac gluten sensitivityIrritable bowel syndromeFood HypersensitivityTriticumAutoantibodies
researchProduct

Assessing the determination of salivary electrolytes and anti-Ro and anti-La antibodies for the diagnosis of Sjogren s syndrome (SS)

2009

The aim of this study was to assess changes in salivary electrolyte flow and composition and the presence of anti-Ro/SSA and anti-La/SSB serum and saliva antibodies and their implications for the non-invasive diagnosis of SS. Study design: 73 patients were studied, divided into the following experimental groups: primary Sjögren syndrome (SSp) (n=15), secondary SS (SSs) (n=17), dry mouth, dry eye without Sjögren?s syndrome (BO) (n=20) and healthy controls (C) (n=21). We conducted a baseline assessment of salivary flow and saliva sampling for the measurement of sodium, chlorine, potassium, calcium and phosphate electrolytes, and the determination of antiRo/SSA and La/SSB antibodies; a serum s…

Malemedicine.medical_specialtySalivaElectrolytesstomatognathic systemInternal medicinemedicineHumansSalivaGeneral DentistryPrimary Sjögren Syndromebiologybusiness.industryMiddle AgedDry mouth:CIENCIAS MÉDICAS [UNESCO]eye diseasesSSS*stomatognathic diseasesEndocrinologySjogren's SyndromeOtorhinolaryngologyAntibodies AntinuclearUNESCO::CIENCIAS MÉDICASbiology.proteinSurgeryFemaleAntibodySjogren smedicine.symptombusinessAnti-SSA/Ro autoantibodies
researchProduct

Response to Cueto Rúa et al.

2013

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGeneral surgeryNon-celiac gluten sensitivityGastroenterologyGliadinSurgerymedicineHumansFemalebusinessFood HypersensitivityTriticumAutoantibodiesThe American journal of gastroenterology
researchProduct